Increased release of kaliuretic peptide during immersion-induced central hypervolemia in cirrhotic humans.
Kaliuretic peptide is a recently discovered potent stimulator of potassium and water excretion. Its role in modulating renal water handling in cirrhotic patients has not been defined. The responses of circulating kaliuretic peptide and atrial natriuretic factor in 8 cirrhotic subjects to water immersion were significantly greater (p < 0.05) than those of 7 healthy volunteers. With cessation of immersion, atrial natriuretic factor decreased within 30 min to preimmersion values, whereas kaliuretic peptide remained significantly elevated > 1 h, suggesting a slower clearance for kaliuretic peptide. The peak diuretic response to immersion corresponded in a temporal fashion to the peak circulating concentration of kaliuretic peptide, suggesting a possible physiological role of kaliuretic peptide in modulating volume homeostasis in cirrhotic humans.
Vesely
D L
DL
Department of Biochemistry, University of South Florida Health Sciences Center, James A. Haley Veterans Hospital, Tampa, USA.
Preston
R
R
Gower
W R
WR
Chiou
S
S
Epstein
M
M
D000328:Adult; D000368:Aged; D009320:Atrial Natriuretic Factor / Q000097:blood*; D001810:Blood Volume / Q000502:physiology*; D004791:Enzyme Inhibitors / Q000097:blood*; D006706:Homeostasis / Q000502:physiology; D006801:Humans; D007101:Immersion / Q000503:physiopathology*; D008103:Liver Cirrhosis / Q000097:blood* / Q000503:physiopathology; D008875:Middle Aged; D009318:Natriuresis / Q000502:physiology; D011188:Potassium / Q000378:metabolism; D011498:Protein Precursors / Q000097:blood*; D000254:Sodium-Potassium-Exchanging ATPase / Q000037:antagonists & inhibitors
D004791:Enzyme Inhibitors; D011498:Protein Precursors; C075322:atrial natriuretic factor precursor (79-98); D009320:Atrial Natriuretic Factor; D000254:Sodium-Potassium-Exchanging ATPase; D011188:Potassium